RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Belhaven Biopharma

Belhaven Biopharma

Discover Belhaven Bio's needle-free Epipen alternative, fast-acting nasal medication for those with a fear of needles.

Latest funding

$10M Series A ·

Source: startupintros.com

Total raised: $21M across 2 sourced rounds

All 2 rounds ↓
Website: belhavenbio.com.
Category: Health and bio.
Sectors: Biotechnology, Clinical Trials, Pharmaceutical.
Stage: Series A.
Based in: Raleigh, United States.
Total raised: $21M in 2 sourced rounds.
Last round: Aug 19, 2025 · 454 days ago.
On Recent Funding since: Oct 1, 2026.

Signals

Website registeredAug 12, 2020 (6 years old)
About Belhaven Biopharma

Safe, allergy relief without injections

Funding rounds

DateRoundAmountLeadSource
Series A$10M—startupintros.com
Seed$11M—fundraisingfox.com

Timeline

  1. Website created

Founders and team

Investors

Companies like Belhaven Biopharma

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/belhaven-biopharma (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy